The U.S. government contributed research to a Gilead remdesivir patent — but didn’t get credit
“This patent illustrates the essence of why collaboration between the public and private sectors is important,” said Duke University law professor Arti Rai.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed